PDS Biotechnology Set to Release Q2 2025 Earnings: What Investors Need to Know

PDS Biotechnology is set to release its quarterly earnings report on August 13. Analysts estimate an EPS of $-0.24. The company has a history of beating EPS estimates, which has led to a 3.05% increase in share price the next day. Long-term shareholders are likely upset given the 60.6% decline in shares over the last 52 weeks.

Title: PDS Biotechnology: Upcoming Earnings Report and Market Expectations

PDS Biotechnology (PDSB) is poised to release its quarterly earnings report on August 13, 2025. Analysts estimate an earnings per share (EPS) of $-0.24, but the company has a history of beating EPS estimates. In the last quarter, PDS Biotechnology reported an EPS of $-0.21, which was $0.04 higher than the estimated $-0.25 [1].

This past performance has resulted in a 3.05% increase in share price the next day. However, long-term shareholders are likely displeased with the 60.6% decline in shares over the last 52 weeks. The stock has been highly volatile, with significant fluctuations in price. On August 12, 2025, the stock gained 13.89%, rising from $1.08 to $1.23 [2].

Analysts and investors are closely watching the earnings report for both earnings performance and guidance for the next quarter. While earnings performance is crucial, market reactions are often driven by guidance. Historical data suggests that positive guidance can lead to significant price movements.

The stock is currently trading at $1.08, and it is expected to open at $1.18 on August 13, 2025, with a possible trading interval of $1.19 to $1.27. This gives a possible move of 7.12% during the day. The stock is considered a buy candidate due to several short-term positive signals, despite being in a falling trend [2].

References:
1. [1] https://www.benzinga.com/insights/earnings/25/08/47069695/insights-into-pds-biotechnologys-upcoming-earnings
2. [2] https://stockinvest.us/stock/PDSB